康桥资本
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Jadeite Medicines Receives Orphan Drug Designation for Odevixibat in Progressive Familial Intrahepatic Cholestasis (PFIC) from the Ministry of Health, Labour and Welfare of Japan and will also initiate Phase 3 Trial of Odevixibat in PFIC in Japan 2023-06-21 09:00
CBC GROUP RELEASES 2022 ESG REPORT 2023-06-01 10:00
Hasten Biopharma Acquires Commercial Rights in China for Roche's Antibiotic Rocephin® 2023-05-04 14:00
CBC GROUP AND MUBADALA CO-LEAD US$315 MILLION FUNDRAISING ROUND FOR HASTEN BIOPHARMA 2023-04-20 13:00
CBC Group Appoints Healthcare Veteran Abbas Hussain as Operating Partner 2023-04-01 10:00
RVAC Medicines announces research collaboration with University of Pennsylvania mRNA Vaccine Pioneer 2023-03-17 21:00
RVAC Medicines Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore 2023-02-21 10:00
CBC Group Appoints Chief Operating Officer, Strengthening the Firm's Global Operational Capabilities 2023-02-01 20:18
Navigating a perfect storm - driving access to healthcare in emerging markets 2022-11-30 15:00
RVAC MEDICINES AND A*STAR TO BUILD CAPABILITIES FOR mRNA PRODUCTION IN SINGAPORE 2022-11-21 10:00
CBC-backed ABio-X appoints pharmaceutical and healthcare veteran Dr. Jeffrey Jonas as CEO 2022-11-10 21:00
CBC Healthcare Infrastructure Platform acquires prime industrial land in Shanghai to develop a high-specifications life science park 2022-11-01 11:00
RVAC Medicines Initiates First-in-Human Clinical Trials for mRNA COVID-19 Vaccine Candidates 2022-09-22 10:00
CBC Welcomes Former Allergan CEO Brent Saunders to Join Hugel Board as Executive Chair 2022-05-20 15:00
RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity 2022-04-27 10:00
ENSEM Therapeutics, a CBC Group-Incubated Biopharma Company, Raises $67 Million in Series A Financing to Develop Small Molecule Medicines for Difficult-to-Drug Targets 2022-04-07 04:00
CBC Group-backed Hasten Biopharma successfully completes acquisition of five cardiovascular and metabolism drugs from Takeda 2022-03-31 15:05
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets 2022-03-21 16:20
Nuance Pharma acquires Sino Health to further strengthen its commercial capabilities and expand pipelines 2022-01-06 14:45
Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China 2021-12-23 07:44
1 2